Jérôme Lugrin

Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


25 publications

2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2009 | 2008 |
 
Transient heat stress protects from severe endothelial damage and dysfunction during prolonged experimental ex-vivo lung perfusion.
Parapanov R., Debonneville A., Allouche M., Lugrin J., Rodriguez-Caro H., Liaudet L., Krueger T., 2024. Frontiers in immunology, 15 p. 1390026. Peer-reviewed.
 
Therapeutic reconditioning of damaged lungs by transient heat stress during ex vivo lung perfusion.
Ojanguren A., Parapanov R., Debonneville A., Lugrin J., Szabo C., Hasenauer A., Rosner L., Gonzalez M., Perentes J.Y., Krueger T. et al., 2023/08. American journal of transplantation, 23 (8) pp. 1130-1144. Peer-reviewed.
The systemic deletion of interleukin-1α reduces myocardial inflammation and attenuates ventricular remodeling in murine myocardial infarction.
Lugrin J., Parapanov R., Milano G., Cavin S., Debonneville A., Krueger T., Liaudet L., 2023/03/10. Scientific reports, 13 (1) p. 4006. Peer-reviewed.
Experimental Models of Ischemic Lung Damage for the Study of Therapeutic Reconditioning During Ex Vivo Lung Perfusion.
Parapanov R., Wang X., Wang Y., Debonneville A., Lugrin J., Liaudet L., Krueger T., 2022/07. Transplantation direct, 8 (7) pp. e1337. Peer-reviewed.
 
Effects of cold or warm ischemia and ex-vivo lung perfusion on the release of damage associated molecular patterns and inflammatory cytokines in experimental lung transplantation.
Hasenauer A., Bédat B., Parapanov R., Lugrin J., Debonneville A., Abdelnour-Berchtold E., Gonzalez M., Perentes J.Y., Piquilloud L., Szabo C. et al., 2021/09. The Journal of heart and lung transplantation, 40 (9) pp. 905-916. Peer-reviewed.
 
Treatment with 3-aminobenzamide during ex vivo lung perfusion of damaged rat lungs reduces graft injury and dysfunction after transplantation.
Wang X., Parapanov R., Debonneville A., Wang Y., Abdelnour-Berchtold E., Gonzalez M., Gronchi F., Perentes J.Y., Ris H.B., Eckert P. et al., 2020/04. American journal of transplantation, 20 (4) pp. 967-976. Peer-reviewed.
Murine Myocardial Infarction Model using Permanent Ligation of Left Anterior Descending Coronary Artery.
Lugrin J., Parapanov R., Krueger T., Liaudet L., 2019/08/16. Journal of visualized experiments 150. Peer-reviewed.
 
Hydrogen sulfide inhibits NLRP3 inflammasome activation and reduces cytokine production both in vitro and in a mouse model of inflammation.
Castelblanco M., Lugrin J., Ehirchiou D., Nasi S., Ishii I., So A., Martinon F., Busso N., 2018/02/16. The Journal of biological chemistry, 293 (7) pp. 2546-2557. Peer-reviewed.
The AIM2 inflammasome: Sensor of pathogens and cellular perturbations.
Lugrin J., Martinon F., 2018/01. Immunological reviews, 281 (1) pp. 99-114. Peer-reviewed.
Sirtuin 3 deficiency does not alter host defenses against bacterial and fungal infections.
Ciarlo E., Heinonen T., Lugrin J., Acha-Orbea H., Le Roy D., Auwerx J., Roger T., 2017/06/20. Scientific reports, 7 (1) p. 3853. Peer-reviewed.
 
Detection of ASC Oligomerization by Western Blotting.
Lugrin J., Martinon F., 2017. Bio-Protocol, 7 (10) pp. NA. Peer-reviewed.
 
Periodic Fever with Aphthous Stomatitis, Pharyngitis, and Cervical Adenitis Syndrome Is Associated with a CARD8 Variant Unable To Bind the NLRP3 Inflammasome.
Cheung M.S., Theodoropoulou K., Lugrin J., Martinon F., Busso N., Hofer M., 2017. Journal of Immunology, 198 (5) pp. 2063-2069. Peer-reviewed.
Pyrrolidine dithiocarbamate administered during ex-vivo lung perfusion promotes rehabilitation of injured donor rat lungs obtained after prolonged warm ischemia.
Francioli C., Wang X., Parapanov R., Abdelnour E., Lugrin J., Gronchi F., Perentes J., Eckert P., Ris H.B., Piquilloud L. et al., 2017. PloS one, 12 (3) pp. e0173916. Peer-reviewed.
Sirtuin 2 Deficiency Increases Bacterial Phagocytosis by Macrophages and Protects from Chronic Staphylococcal Infection.
Ciarlo E., Heinonen T., Théroude C., Herderschee J., Mombelli M., Lugrin J., Pfefferlé M., Tyrrell B., Lensch S., Acha-Orbea H. et al., 2017. Frontiers in immunology, 8 p. 1037. Peer-reviewed.
AIM2 inflammasome is activated by pharmacological disruption of nuclear envelope integrity.
Di Micco A., Frera G., Lugrin J., Jamilloux Y., Hsu E.T., Tardivel A., De Gassart A., Zaffalon L., Bujisic B., Siegert S. et al., 2016/08/09. Proceedings of the National Academy of Sciences of the United States of America, 113 (32) pp. E4671-80. Peer-reviewed.
Cutting edge: IL-1α is a crucial danger signal triggering acute myocardial inflammation during myocardial infarction.
Lugrin J., Parapanov R., Rosenblatt-Velin N., Rignault-Clerc S., Feihl F., Waeber B., Müller O., Vergely C., Zeller M., Tardivel A. et al., 2015. Journal of Immunology, 194 (2) pp. 499-503. Peer-reviewed.
 
Toll-like receptor 5 deficiency exacerbates cardiac injury and inflammation induced by myocardial ischaemia-reperfusion in the mouse.
Parapanov R., Lugrin J., Rosenblatt-Velin N., Feihl F., Waeber B., Milano G., Vergely C., Li N., Pacher P., Liaudet L., 2015. Clinical Science, 129 (2) pp. 187-198. Peer-reviewed.
The role of oxidative stress during inflammatory processes.
Lugrin J., Rosenblatt-Velin N., Parapanov R., Liaudet L., 2014. Biological Chemistry, 395 (2) pp. 203-230.
 
The sirtuin inhibitor cambinol impairs MAPK signaling, inhibits inflammatory and innate immune responses and protects from septic shock.
Lugrin J., Ciarlo E., Santos A., Grandmaison G., dos Santos I., Le Roy D., Roger T., 2013. Biochimica et Biophysica Acta, 1833 (6) pp. 1498-1510.
 
Epigenetic control of MIF expression
Roger T., Lugrin J., Ding X.C., Calandra T., 2012. pp. 121-128 dans Bucala R. (eds.) The MIF Handbook, World Scientific Publishing.
 
Impact of Sirtuin 2 knockout on innate immune responses
Ciarlo E., Lugrin J., dos Santos Pinheiro I., Le Roy D., Moulan N., Yamamoto H., Acha-Orbea H., Calandra T., Auwerx J., Roger T., 2012. p. 271 dans European Congress of Immunology, Immunology.
Histone deacetylase inhibitors impair antibacterial defenses of macrophages.
Mombelli M., Lugrin J., Rubino I., Chanson A.L., Giddey M., Calandra T., Roger T., 2011. Journal of Infectious Diseases, 204 (9) pp. 1367-1374.
 
Histone deacetylase inhibitors impair innate immune responses to Toll-like receptor agonists and to infection.
Roger T., Lugrin J., Le Roy D., Goy G., Mombelli M., Koessler T., Ding X.C., Chanson A.L., Reymond M.K., Miconnet I. et al., 2011. Blood, 117 (4) pp. 1205-1217.
 
Histone deacetylase inhibitors repress macrophage migration inhibitory factor (MIF) expression by targeting MIF gene transcription through a local chromatin deacetylation.
Lugrin J., Ding X.C., Le Roy D., Chanson A.L., Sweep F.C., Calandra T., Roger T., 2009. Biochimica et Biophysica Acta-Molecular Cell Research, 1793 (11) pp. 1749-1758. Peer-reviewed.
 
Inhibitors of histone deacetylases impair innate immune responses of macrophages : P215
Mombelli M., Francois P., Giddey M., Reymond M.K., Lugrin J., Schrenzel J., Calandra T., Roger T., 2008. pp. 49S-50S dans Annual Joint Meeting of the Swiss Societies for Pneumology, Paediatric Pneumology, Allergology and Immunology, Thoracic Surgery, Swiss Medical Weekly. Peer-reviewed.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Swiss University